HomeTrandolapril And Verapamil HydrochlorideTrandolapril And Verapamil Hydrochloride + Rapamycin

Does Trandolapril And Verapamil Hydrochloride Interact with Rapamycin?

Trandolapril And Verapamil Hydrochloride and Rapamycin have a moderate drug interaction according to U.S. FDA drug labeling data. Mammalian Target of Rapamycin (mTOR) Inhibitors Patients taking concomitant mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see WARNINGS - Angioedema ). Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Trandolapril And Verapamil Hydrochloride Class
Angiotensin Converting Enzyme Inhibitor
Rapamycin Class
mTOR Inhibitor Immunosuppressant
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Trandolapril And Verapamil Hydrochloride and your doctor is considering prescribing Rapamycin (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Trandolapril And Verapamil Hydrochloride(Trandolapril And Verapamil Hydrochloride)+💊 Rapamycin

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Angiotensin Converting Enzyme Inhibitor
Drug B class
mTOR Inhibitor Immunosuppressant
Source
FDA drug label - trandolapril and verapamil hydrochloride

What this means in plain English

Mammalian Target of Rapamycin (mTOR) Inhibitors Patients taking concomitant mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see WARNINGS - Angioedema ).

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Trandolapril And Verapamil Hydrochloride and Rapamycin against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.